Popular Stories
- Globalstar – Aiming for th
- CytoKinetics – On the Thre
- Rigel Pharmaceuticals has
- 5 Biotech Companies That S
- 3 Reasons Why INNODATA Inc
- Ontrak Inc – Leveraging Ar
SAMPLE REPORTS
- Company Summary.pdf
- Daily Market Updates.pdf
- Initiating Coverage.pdf
- Investors' Presentation.pdf
- Portfolio Performance Analysis.pdf
- Pre-Result Analysis.pdf
- Result Review.pdf
- Short Initiating Coverage.pdf

PULMATRIX Inc Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Pulmatrix Soars on News of Licensing Agreement with Johnson & Johnson

Pulmatrix Inc (NASDAQ: PULM), a Clinical Stage Biopharmaceutical Company developing inhaled therapies for the treatment of pulmonary diseases, announced the signing of a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson (NYSE: JNJ), enabling the initiative to access the Company’s...

06 January, 2020 0 Comments
New therapeutics promise respite to patients suffering from COPD

Chronic Obstructive Pulmonary Disease (COPD) is a progressive and irreversible degeneration of the lungs which is characterised by difficulty in breathing and poor airflow and manifests itself as diseases such as emphysema, chronic bronchitis and refractory (non-reversible) asthma. The World Health Organization (WHO) estimates that there...

27 February, 2019 0 Comments
WordPress Video Lightbox Plugin